| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bioactive analogs that simulate subsets of biological activities of 1α,25(OH)2D3 in osteoblasts
|
Farach-Carson, Mary C.
|
|
2001
|
66 |
3-5 |
p. 357-361
5 p.
|
artikel
|
| 2 |
Central role of VDR conformations for understanding selective actions of vitamin D3 analogues
|
Carlberg, Carsten
|
|
2001
|
66 |
3-5 |
p. 213-221
9 p.
|
artikel
|
| 3 |
Conformationally restricted mimics of vitamin D rotamers
|
Okamura, William H.
|
|
2001
|
66 |
3-5 |
p. 239-247
9 p.
|
artikel
|
| 4 |
Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene
|
Lian, Jane B.
|
|
2001
|
66 |
3-5 |
p. 159-170
12 p.
|
artikel
|
| 5 |
Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis
|
Nakagawa, Kimie
|
|
2001
|
66 |
3-5 |
p. 327-337
11 p.
|
artikel
|
| 6 |
Differential regulation of heterodimerization by 1α,25-dihydroxyvitamin D3 and its 20-epi analog
|
Liu, Yan-Yun
|
|
2001
|
66 |
3-5 |
p. 203-212
10 p.
|
artikel
|
| 7 |
Different shapes of the steroid hormone 1α,25(OH)2-vitamin D3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses☆ 1 1 ☆ Guest Editor: Dr. Satya Reddy, Proceedings of the First International Conference on Chemistry and Biology of Vitamin D Analogs, Brown University, Providence, RI.
|
Norman, Anthony W.
|
|
2001
|
66 |
3-5 |
p. 147-158
12 p.
|
artikel
|
| 8 |
24,25-Dihydroxyvitamin D3 and bone metabolism
|
van Leeuwen, Johannes P.T.M.
|
|
2001
|
66 |
3-5 |
p. 375-380
6 p.
|
artikel
|
| 9 |
1α,25-dihydroxyvitamin D3 displays divergent growth effects in both normal and malignant cells
|
Rashid, Samantha F
|
|
2001
|
66 |
3-5 |
p. 433-440
8 p.
|
artikel
|
| 10 |
Editorial
|
Reddy, G.Satyanarayana
|
|
2001
|
66 |
3-5 |
p. 127-128
2 p.
|
artikel
|
| 11 |
Functions of 1α,25-dihydroxyvitamin D3 in mammary gland: from normal development to breast cancer
|
Narvaez, Carmen J
|
|
2001
|
66 |
3-5 |
p. 301-308
8 p.
|
artikel
|
| 12 |
Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways
|
Uskokovic, Milan R.
|
|
2001
|
66 |
3-5 |
p. 463-471
9 p.
|
artikel
|
| 13 |
History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
|
Nishii, Y.
|
|
2001
|
66 |
3-5 |
p. 137-146
10 p.
|
artikel
|
| 14 |
25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis
|
Cross, Heide S.
|
|
2001
|
66 |
3-5 |
p. 287-292
6 p.
|
artikel
|
| 15 |
Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells
|
Pirianov, Grisha
|
|
2001
|
66 |
3-5 |
p. 309-318
10 p.
|
artikel
|
| 16 |
Metabolism of 1α,25-dihydroxyvitamin D3 and its C-3 epimer 1α,25-dihydroxy-3-epi-vitamin D3 in neonatal human keratinocytes
|
Reddy, G.Satyanarayana
|
|
2001
|
66 |
3-5 |
p. 441-450
10 p.
|
artikel
|
| 17 |
Metabolism of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1α,25-dihydroxyvitamin D3 produced in HL-60 cells
|
Sunita Rao, D
|
|
2001
|
66 |
3-5 |
p. 423-431
9 p.
|
artikel
|
| 18 |
Metabolites and analogs of 1α,25-dihydroxyvitamin D3: evaluation of actions in bone
|
Kadiyala, Sudha
|
|
2001
|
66 |
3-5 |
p. 347-355
9 p.
|
artikel
|
| 19 |
Novel side chain analogs of 1α,25-dihydroxyvitamin D3: design and synthesis of the 21,24-methano derivatives
|
Calverley, Martin J.
|
|
2001
|
66 |
3-5 |
p. 249-255
7 p.
|
artikel
|
| 20 |
24,25-(OH)2D3 regulates cartilage and bone via autocrine and endocrine mechanisms
|
Boyan, Barbara D.
|
|
2001
|
66 |
3-5 |
p. 363-374
12 p.
|
artikel
|
| 21 |
On becoming a molecular endocrinologist
|
Norman, Anthony W.
|
|
2001
|
66 |
3-5 |
p. 129-136
8 p.
|
artikel
|
| 22 |
Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway
|
Omdahl, J.L
|
|
2001
|
66 |
3-5 |
p. 381-389
9 p.
|
artikel
|
| 23 |
(23S)- and (23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1α,25-dihydroxyvitamin D3
|
Ishizuka, Seiichi
|
|
2001
|
66 |
3-5 |
p. 227-237
11 p.
|
artikel
|
| 24 |
Selective inhibition of vitamin D hydroxylases in human keratinocytes 1 1 Abbreviations: VD: vitamin D3; 25(OH)D3: 25-hydroxyvitamin D3; 3H-25(OH)D3: [26,27n-3H] 25-hydroxyvitamin D3; 1α,25(OH)2D3: 1α,25-dihydroxyvitamin D3; 1α,25(OH)2-3epi-D3: 1α,25-dihydroxyvitamin-3-epi-D3; 1α,24(R),25(OH)3D3: 1α,24(R),25-trihydroxyvitamin D3, 1α,25(OH)2-24oxo-D3: 1α,25-dihydroxy-24oxo-vitamin D3; 1α,23(S),25(OH)3-24oxo-D3: 1α,23(S),25-trihydroxy-24oxo-vitamin D3; calcitroic acid: 1α-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3; CYP: cytochrome P450; 1α-hydroxylase: 25-hydroxyvitamin D3-1α-hydroxylase; 24-hydroxylase (CYP24), 1α,25-hydroxyvitamin D3-24-hydroxylase; PHK, primary human keratinocytes; KGM: keratinocyte growth medium; HPLC, high performance liquid chromatography; IC50: half-maximum inhibitor concentration; SD: standard deviation.
|
Schuster, I
|
|
2001
|
66 |
3-5 |
p. 409-422
14 p.
|
artikel
|
| 25 |
Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes
|
Schuster, I
|
|
2001
|
66 |
3-5 |
p. 451-462
12 p.
|
artikel
|
| 26 |
Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases
|
Schuessler, Monika
|
|
2001
|
66 |
3-5 |
p. 399-408
10 p.
|
artikel
|
| 27 |
Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids
|
Steinmeyer, Andreas
|
|
2001
|
66 |
3-5 |
p. 257-266
10 p.
|
artikel
|
| 28 |
Synthesis and biological characterization of 1α,24,25-trihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (24-hydroxylated ED-71)
|
Hatakeyama, Susumi
|
|
2001
|
66 |
3-5 |
p. 267-276
10 p.
|
artikel
|
| 29 |
Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1α,25-dihydroxyvitamin D3 and 20-epi-2-methyl-1α,25-dihydroxyvitamin D3
|
Takayama, Hiroaki
|
|
2001
|
66 |
3-5 |
p. 277-285
9 p.
|
artikel
|
| 30 |
The effects of 1α,24(S)-dihydroxyvitamin D2 analog on cancer cell proliferation and cytokine expression
|
Shany, Shraga
|
|
2001
|
66 |
3-5 |
p. 319-325
7 p.
|
artikel
|
| 31 |
The 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme?
|
Henry, Helen L.
|
|
2001
|
66 |
3-5 |
p. 391-398
8 p.
|
artikel
|
| 32 |
The role of phospholipase C-γ1 in 1α,25-dihydroxyvitamin D3 regulated keratinocyte differentiation
|
Xie, Zhongjian
|
|
2001
|
66 |
3-5 |
p. 339-345
7 p.
|
artikel
|
| 33 |
The role of vitamin D in prostate cancer
|
Zhao, Xiao-Yan
|
|
2001
|
66 |
3-5 |
p. 293-300
8 p.
|
artikel
|
| 34 |
Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model
|
Yamada, Sachiko
|
|
2001
|
66 |
3-5 |
p. 177-187
11 p.
|
artikel
|
| 35 |
Vitamin D3 analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action
|
Mäenpää, Pekka H.
|
|
2001
|
66 |
3-5 |
p. 223-225
3 p.
|
artikel
|
| 36 |
Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription
|
MacDonald, Paul N
|
|
2001
|
66 |
3-5 |
p. 171-176
6 p.
|
artikel
|
| 37 |
Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α,25-dihydroxyvitamin D3 receptor?☆
|
Mohr, Scott C.
|
|
2001
|
66 |
3-5 |
p. 189-201
13 p.
|
artikel
|
Tijdschrift beschrijving